Comments on: Waxman To FDA: Watch Those Journal Articles http://www.pharmalot.com/2007/11/waxman-to-fda-watch-those-journal-articles/ News, Comment and Conversation Thu, 18 Mar 2010 13:36:44 +0000 http://wordpress.org/?v=2.6.2 By: William Hill http://www.pharmalot.com/2007/11/waxman-to-fda-watch-those-journal-articles/#comment-45595 William Hill Tue, 18 Dec 2007 05:39:06 +0000 http://www.pharmalot.com/2007/11/waxman-to-fda-watch-those-journal-articles/#comment-45595 Providing healthcare professionals and patients with comprehensive information about prescriptions will help ensure safe and optimal use of drugs. This means better health outcomes for patients and more efficient delivery of healthcare in the United States. By making package inserts more useful for healthcare providers in their day-to-day practices, we are making it easier for them to explain the risks and benefits of medications for their patients. Approximately 300,000 preventable adverse events occur in hospitals in the United States, many as a result of confusing and complicated medical information. Prioritizing the Warning Label can help in reducing such events. Providing healthcare professionals and patients with comprehensive information about prescriptions will help ensure safe and optimal use of drugs. This means better health outcomes for patients and more efficient delivery of healthcare in the United States. By making package inserts more useful for healthcare providers in their day-to-day practices, we are making it easier for them to explain the risks and benefits of medications for their patients.

Approximately 300,000 preventable adverse events occur in hospitals in the United States, many as a result of confusing and complicated medical information. Prioritizing the Warning Label can help in reducing such events.

]]> By: Not Soandso http://www.pharmalot.com/2007/11/waxman-to-fda-watch-those-journal-articles/#comment-29788 Not Soandso Sun, 02 Dec 2007 17:23:43 +0000 http://www.pharmalot.com/2007/11/waxman-to-fda-watch-those-journal-articles/#comment-29788 FDA & labeling: The media has focused on toy safety as it should, but seems to be ignoring the huge danger from the lack of proper labeling of medicine. Look in your medicine cabinet and tell me the country of origin for your prescription & non-prescription drugs. That's right no requirements for the country of origin on medicine or where the ingredients came from. This is a perfect opportunity to assist the counterfeiters in marketing their crap with one less thing for them to worry about. Your toys, shirts, & underwear must be labeled but not your pills. Are those fish oil pills from fish in a polluted pond in China.... who knows? Perhaps it because of the conflict of interest of the drug manufactures that don't want you to know. Another example of the Government/FDA not doing its job ......... Why is it not a requirement that ALL retail products including your drugs be labeled with the country of origin. FDA & labeling: The media has focused on toy safety as it should, but seems to be ignoring the huge danger from the lack of proper labeling of medicine. Look in your medicine cabinet and tell me the country of origin for your prescription & non-prescription drugs. That’s right no requirements for the country of origin on medicine or where the ingredients came from. This is a perfect opportunity to assist the counterfeiters in marketing their crap with one less thing for them to worry about. Your toys, shirts, & underwear must be labeled but not your pills. Are those fish oil pills from fish in a polluted pond in China…. who knows? Perhaps it because of the conflict of interest of the drug manufactures that don’t want you to know. Another example of the Government/FDA not doing its job ……… Why is it not a requirement that ALL retail products including your drugs be labeled with the country of origin.

]]> By: Hank http://www.pharmalot.com/2007/11/waxman-to-fda-watch-those-journal-articles/#comment-29696 Hank Sat, 01 Dec 2007 18:41:00 +0000 http://www.pharmalot.com/2007/11/waxman-to-fda-watch-those-journal-articles/#comment-29696 As many of you know, this struggle has been going on for some time. The Washington Legal Foundation - and former FDA Chief Counsel Dan Troy (of FDA preemption fame) - have taken point. Beyond what Waxman says, it seems to me the proposed guielines are so Byzantine that they would simply be unenforceable. And we would end up with the Wild West, which is, indeed, some folks view of "freedom of commercial speech." Welcome to Dodge. As many of you know, this struggle has been going on for some time. The Washington Legal Foundation - and former FDA Chief Counsel Dan Troy (of FDA preemption fame) - have taken point.

Beyond what Waxman says, it seems to me the proposed guielines are so Byzantine that they would simply be unenforceable. And we would end up with the Wild West, which is, indeed, some folks view of “freedom of commercial speech.”

Welcome to Dodge.

]]> By: Friday Blog Roundup « The Pump Handle http://www.pharmalot.com/2007/11/waxman-to-fda-watch-those-journal-articles/#comment-29596 Friday Blog Roundup « The Pump Handle Fri, 30 Nov 2007 22:59:34 +0000 http://www.pharmalot.com/2007/11/waxman-to-fda-watch-those-journal-articles/#comment-29596 [...] Ed Silverman at Pharmalot explains Congressman Waxman’s concerns a new FDA draft guidance about distributing journal articles. [...] [...] Ed Silverman at Pharmalot explains Congressman Waxman’s concerns a new FDA draft guidance about distributing journal articles. [...]

]]>